66464 Federal Register / Vol. 88, No. 186 / Wednesday, September 27, 2023 / Notices 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; R13 

Conference Grant Review. 

Date: November 14–15, 2023. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W542, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Biman Chandra Paria, 

Ph.D., Scientific Review Officer, Program 

Coordination and Referral Branch, Division 

of Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W542, Rockville, Maryland 20850, 

240–858–3814, pariab@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SBIR Phase 

IIB Bridge Awards. 

Date: November 16, 2023. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W238, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Jeffrey E. DeClue, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W238, Rockville, Maryland 

20850, 240–276–6371, decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Small 

Business Transition Grant for Early Career 

Scientists. 

Date: November 30, 2023. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W238, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Jeffrey E. DeClue, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W238, Rockville, Maryland 

20850, 240–276–6371, decluej@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 21, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20956 Filed 9–26–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Translational Immuno-oncology 

Study Section. 

Date: October 19–20, 2023. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, Bethesda, MD 

20814. 

Contact Person: Maria Elena 

Cardenas-Corona, Ph.D.. Scientific 

Review Officer, Center for Scientific 

Review, National Institutes of Health, 

6701 Rockledge Drive, Bethesda, MD 

20817, 301–867–5309, maria.cardenascorona@nih.gov. 

Name of Committee: Infectious 

Diseases and Immunology B Integrated 

Review Group; Transplantation, 

Tolerance, and Tumor Immunology 

Study Section. 

Date: October 19–20, 2023. 

Time: 8:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Canopy by Hilton, 940 Rose 

Avenue, North Bethesda, MD 20852. 

Contact Person: Carmen Angeles 

Ufret-Vincenty, Ph.D., Scientific Review 

Officer, Center for Scientific Review, 

National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(301) 594–0912, carmen.ufret-vincenty@

nih.gov. 

Name of Committee: Molecular, 

Cellular and Developmental 

Neuroscience Integrated Review Group; 

Molecular and Cellular 

Neuropharmacology Study Section. 

Date: October 19–20, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Vanessa S Boyce, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Rm. 

4185, MSC 7850, Bethesda, MD 20892, 

(301) 402–3726, boycevs@csr.nih.gov. 

Name of Committee: Center for 

Scientific Review Special Emphasis 

Panel; Collaborative Applications: 

Clinical Studies of Mental Illness. 

Date: October 19, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Allison Kurti, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 

1007J, Bethesda, MD 20892, (301) 594– 

1814, kurtian@csr.nih.gov. 

Name of Committee: Population 

Sciences and Epidemiology Integrated 

Review Group; Neurological, Mental 

and Behavioral Health Study Section. 

Date: October 19–20, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Allison Kurti, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 

1007J, Bethesda, MD 20892, (301) 594– 

1814, kurtian@csr.nih.gov. 

Name of Committee: Vascular and 

Hematology Integrated Review Group; 

Hemostasis, Thrombosis, Blood Cells 

and Transfusion Study Section. 

Date: October 19–20, 2023. 

Time: 9:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Vivian Tang, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 186 / Wednesday, September 27, 2023 / Notices 66465 

Health, 6701 Rockledge Drive, Bethesda, 

MD 20892, (301) 594–6208, tangvw@

csr.nih.gov. 

Name of Committee: Emerging 

Technologies and Training 

Neurosciences Integrated Review Group; 

Bioengineering of Neuroscience, Vision 

and Low Vision Technologies Study 

Section, Bioengineering of Neuroscience 

and Vision Technologies. 

Date: October 19–20, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Tina Tze-Tsang Tang, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Suite 

3030, Bethesda, MD 20817, (301) 435– 

4436, tangt@mail.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group; Learning, 

Memory and Decision Neuroscience 

Study Section. 

Date: October 19–20, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Roger Janz, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, 

MD 20892, (301) 402–8515, janzr2@

csr.nih.gov. 

Name of Committee: Genes, Genomes, 

and Genetics Integrated Review Group; 

Genetic Variation and Evolution Study 

Section. 

Date: October 19–20, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: North Bethesda Marriott Hotel 

& Conference Center, Montgomery 

County Conference Center Facility, 5701 

Marinelli Road, North Bethesda, MD 

20852. 

Contact Person: Guoqin Yu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, 

MD 20892, (301) 435–1276, guoqin.yu@

nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Molecular Cancer Diagnosis and 

Classification Study Section. 

Date: October 19–20, 2023. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: North Bethesda Marriott Hotel 

& Conference Center, Montgomery 

County Conference Center Facility, 5701 

Marinelli Road, North Bethesda, MD 

20852. 

Contact Person: Lawrence Ka-Yun Ng, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

6152, MSC 7804 Bethesda, MD 20892, 

301–435–1719, ngkl@csr.nih.gov. 

Name of Committee: Biobehavioral 

and Behavioral Processes Integrated 

Review Group; Adult Psychopathology 

and Disorders of Aging Study Section. 

Date: October 19–20, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Benjamin G Shapero, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

3182, MSC 7848, Bethesda, MD 20892, 

(301) 402–4786, shaperobg@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 21, 2023. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20977 Filed 9–26–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

[OMB Control Number 1651–0121] 

Agency Information Collection 

Activities; Revision of Existing 

Collection; Trusted Traveler Programs 

and U.S. APEC Business Travel Card 

AGENCY: U.S. Customs and Border 

Protection (CBP), Department of 

Homeland Security. 

ACTION: 30-Day Notice and request for 

comments; revision of an existing 

collection of information. 

SUMMARY: The Department of Homeland 

Security, U.S. Customs and Border 

Protection will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995 (PRA). The 

information collection is published in 

the Federal Register to obtain comments 

from the public and affected agencies. 

DATES: Comments are encouraged and 

must be submitted (no later than 

October 27, 2023) to be assured of 

consideration. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain . Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional PRA information 

should be directed to Seth Renkema, 

Chief, Economic Impact Analysis 

Branch, U.S. Customs and Border 

Protection, Office of Trade, Regulations 

and Rulings, 90 K Street NE, 10th Floor, 

Washington, DC 20229–1177, 

Telephone number 202–325–0056 or via 

email CBP_PRA@cbp.dhs.gov. Please 

note that the contact information 

provided here is solely for questions 

regarding this notice. Individuals 

seeking information about other CBP 

programs should contact the CBP 

National Customer Service Center at 

877–227–5511, (TTY) 1–800–877–8339, 

or CBP website at https://www.cbp.gov/ 

. 

SUPPLEMENTARY INFORMATION: CBP 

invites the general public and other 

Federal agencies to comment on the 

proposed and/or continuing information 

collections pursuant to the Paperwork 

Reduction Act of 1995 (44 U.S.C. 3501 

et seq.). This proposed information 

collection was previously published in 

the Federal Register (87 FR 33178) on 

June 01, 2022, allowing for a 60-day 

comment period. This notice allows for 

an additional 30 days for public 

comments. This process is conducted in 

accordance with 5 CFR 1320.8. Written 

comments and suggestions from the 

public and affected agencies should 

address one or more of the following 

four points: (1) whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; (2) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

suggestions to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) suggestions to 

minimize the burden of the collection of 


ddrumheller on DSK120RN23PROD with NOTICES1